Compare FormFactor Inc. FormFactor Inc. Common Stock (FORM) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FormFactor Inc. FormFactor Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? FormFactor Inc. FormFactor Inc. Common Stock trades at $141.38 (market cap $10.92B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.52 (market cap $5.85B). The key difference: FormFactor Inc. FormFactor Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,517,176 versus 1,056,924). Which is the better fit depends on your goals — on Pluang, investors hold FormFactor Inc. FormFactor Inc. Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FORM | IOVA | |
|---|---|---|
Market Cap | $10.92B | $5.85B |
Volume | 1,056,924 | 14,517,176 |
Sector | Technology | Health |
52-Week High | $159.93 | $14.82 |
52-Week Low | $38.14 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.61B | $5.78B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FormFactor Inc. FormFactor Inc. Common Stock
FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
